Live Poll Results — What pricing strategy allowed Alexion's Soliris, a treatment for rare blood diso
See real-time poll results. Powered by AIPolls.Net.
Pharma Pricing Strategies: The Orphan Drug Phenomenon
In the pharmaceutical industry, pricing strategies can significantly impact both patient access and company profitability. 'Orphan drugs' represent a fascinating case study in medical product pricing. These medications treat rare diseases affecting small patient populations, yet they often command premium prices. Test your knowledge about this specialized pricing strategy that has transformed the economics of rare disease treatment.
What pricing strategy allowed Alexion's Soliris, a treatment for rare blood disorders, to become one of the world's most expensive drugs at over $500,000 per patient annually?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Value-based pricing justified by life-saving efficacy and the extreme rarity of target conditions', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Loss-leader pricing to gain market share before introducing more profitable follow-up medications', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Bundle pricing combining multiple rare disease treatments into a single payment package', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Subscription-based pricing where hospitals pay a fixed annual fee for unlimited patient access', 'is_correct': False} | 0 | 0% |